Welcome to our dedicated page for Origin Agritech news (Ticker: SEED), a resource for investors and traders seeking the latest updates and insights on Origin Agritech stock.
Origin Agritech Limited develops agricultural technology and crop seed biotechnology in China, with news centered on corn seed R&D, genetic improvement, commercialization programs, and regulatory authorizations for crop seed production and GMO-related operations. Company updates frequently cover new corn varieties such as Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, as well as distributor initiatives including the Golden Harvest Club.
Recurring developments also include biotechnology pipeline work involving glyphosate tolerance, Bt pest-resistance traits, phytase corn, gene editing technology, research collaborations, market expansion in Chinese agricultural regions, annual results, financing actions, and board or finance leadership changes.
Origin Agritech Ltd. (NASDAQ: SEED) has announced a collaboration with the Biotechnology Research Institute (BRI) to enhance GMO soybean research and commercialization. This partnership will focus on developing GMO soybean varieties with enhanced drought and salt-alkaline tolerances, in addition to existing glyphosate tolerance traits. Origin has exclusive commercial rights to certain GMO crops developed by BRI. The agreement aims to boost soybean production and benefits farmers in China and globally.